A pilot study to evaluate the co-infusion of ex vivo expanded umbilical cord blood progenitors with an unmanipulated cord blood graft in patients undergoing umbilical cord blood transplantation for hematologic malignancies.
Latest Information Update: 07 Apr 2022
At a glance
- Drugs Dilanubicel (Primary) ; Fludarabine (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate mofetil (Primary) ; Ciclosporin; Ciclosporin; Cyclophosphamide
- Indications Acute myeloid leukaemia; Burkitt's lymphoma; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Follicular lymphoma; Graft-versus-host disease; Haematological malignancies; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Jul 2013 Planned end date changed from 1 Aug 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 14 Jan 2013 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.